Abstract
Typhoid is a major public health threat, particularly in areas lacking access to clean water, proper nutrition, and hygienic practices. The emergence of antibiotic resistance, inaccessibility of vaccines to the global south, and asymptomatic carriers of Salmonella typhi (S. typhi) have made tackling the scourge of typhoid a major challenge. Plant-based antimicrobial compounds have opened a new avenue for effectively managing typhoid by minimizing drug-related side effects and targeting the resistant strains of typhoidal salmonella cost-effectively. This review article contains many such candidates, who can potentially modify the typhoid treatment guidelines like Azadirachta indica, Canarium schweinfurthii-derived scopoletin, and Punic granatum, and those that target the resistant strains of S. typhi, like Amaranthus hybridus, and Quercus infectoria and Phyllanthus emblica. The article will also shed light on the challenges and promises associated with phytocompound extraction and standardization as the researchers navigate the uncharted waters of alternative medicinal sources.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
More From: Microbiological & Immunological Communications
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.